UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 30, 2021
Bright Health Group, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-40537 | 47-4991296 | ||||||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
8000 Norman Center Drive Suite 1200, Minneapolis, Minnesota | 55437 | |||||||
Address of Principal Executive Office | (Zip Code) |
(612) 238-1321
Registrant's telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, $0.0001 par value per share | BHG | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 7.01 Regulation FD Disclosure.
NeueHealth Release
On November 30, 2021, Bright Health Group, Inc. (the "Company"), issued a news release regarding its NeueHealth business. A copy of the news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Investor Day
On November 30, 2021, the Company also announced that it will host an Investor Day on December 7, 2021 beginning at 8:00 a.m. Eastern Time. The Investor Day will feature updates from management about the Company’s business, strategies, and outlook for 2022 followed by a question and answer period. A webcast link for the live presentation will be available on the Company’s Investor Relations page at http://investors.brighthealthgroup.com. A copy of the materials to be presented by the Company at such Investor Day will also be available on the Company’s Investor Relations website.
Participants are encouraged to join at least 15 minutes prior to the start of the Investor Day event. A recording of the Investor Day presentation will be available on the Company’s Investor Relations page for at least one week following the call.
The information in Item 7.01 and Exhibit 99.1 of this Current report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | The cover page from the Current Report on Form 8-K formatted in Inline XBRL. | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BRIGHT HEALTH GROUP, INC. | |||||||||||
Date: | November 30, 2021 | By: | /s/ Keith Nelsen | ||||||||
Name: | Keith Nelsen | ||||||||||
Title: | General Counsel and Corporate Secretary |